Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA.

Similar documents
Deep Brain Stimulation for Parkinson s Disease & Essential Tremor

DEEP BRAIN STIMULATION

EMERGING TREATMENTS FOR PARKINSON S DISEASE

Surgical Treatment for Movement Disorders

PACEMAKERS ARE NOT JUST FOR THE HEART! Ab Siadati MD

Deep Brain Stimulation and Movement Disorders

Deep Brain Stimulation: Indications and Ethical Applications

Epilepsy & Functional Neurosurgery

symptoms of Parkinson s disease EXCEPT.

See Policy CPT/HCPCS CODE section below for any prior authorization requirements

Punit Agrawal, DO Clinical Assistant Professor of Neurology Division of Movement Disorders OSU Department of Neurology

Introduction to Neurosurgical Subspecialties:

Surgical Treatment: Patient Edition

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Surgical Treatment of Movement Disorders. Surgical Treatment of Movement Disorders. New Techniques: Procedure is safer and better

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.

Shobana Rajan, M.D. Associate staff Anesthesiologist, Cleveland Clinic, Cleveland, Ohio

EMG, EEG, and Neurophysiology in Clinical Practice

PRACTICE GUIDELINE. DEFINITIONS: Mild head injury: Glasgow Coma Scale* (GCS) score Moderate head injury: GCS 9-12 Severe head injury: GCS 3-8

Deep Brain Stimulation Surgery for Parkinson s Disease

Parkinson disease: Parkinson Disease

Epilepsy Surgery, Imaging, and Intraoperative Neuromonitoring: Surgical Perspective

The Changing Surgical Landscape in Kids

SUPPLEMENTAL DIGITAL CONTENT

Intraoperative Monitoring: Role in Epilepsy Based Tumor Surgery December 2, 2012

Deep Brain Stimulation: Surgical Process

Research Perspectives in Clinical Neurophysiology

EPILEPSY 2018: UPDATE ON MODERN SURGICAL MANAGEMENT. Robert Kellogg, MD Advocate Children s Hospital Park Ridge, IL April 20, 2018

Deep brain stimulation: What can patients expect from it?

The American Approach to Depth Electrode Insertion December 4, 2012

Deep Brain Stimulation: Patient selection

Surgical Management of Parkinson s Disease

ChosingPhase 2 Electrodes

Standardize comprehensive care of the patient with severe traumatic brain injury

Interictal High Frequency Oscillations as Neurophysiologic Biomarkers of Epileptogenicity

The possibility of deep brain stimulation to treat eating disorders.

Neuromodulation Approaches to Treatment Resistant Depression

Traumatic Brain Injuries

HealthTalks. Deep Brain Stimulation for Parkinson s Disease Patients

Over the last 20 years, Deep Brain Stimulation (DBS)

Basal ganglia motor circuit

Deep Brain Stimulation for Treatment of Parkinson s Disease Deep brain stimulation, Parkinson s disease, subthalamic nucleus, stereotactic surgery

Surgery for Medically Refractory Focal Epilepsy

PARKINSON S SYMPTOM TRACKER

Medical Review Criteria Implantable Neurostimulators

Efficient Feature Extraction and Classification Methods in Neural Interfaces

Intracranial Studies Of Human Epilepsy In A Surgical Setting

21 ST CENTURY TECHNOLOGY IN PEDIATRIC NEUROLOGIC DISORDERS PEDIATRIC NEUROLOGIC DISORDERS YOUR LEARNING EXPERIENCE LEARNING OBJECTIVES

Deep Brain Stimulation (DBS)

Deep Brain Stimulation

Deep Brain Stimulation For Parkinson s Disease

THE EFFECTS OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION ON VOCAL TRACT DYNAMICS IN PARKINSON S DISEASE

Ablative procedures for the treatment of Parkinson s disease

Parkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. What is Parkinson s Disease?

Original Policy Date

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy (all ages) NHS England Reference: P

This quiz is being published on behalf of the Education Committee of the SNACC.

Deep Brain Stimulation. Is It Right for You?

AT THE FOREFRONT OF MENDING THE BRAIN

Deep Brain Stimulation

ASSFN Clinical Case: Bilateral STN DBS Implant for Parkinson s Disease

Clinical Commissioning Policy Proposition:

Functional Neuroanatomy and Physiology for Movement Disorders

DBS Programming. Paul S Fishman MD, PhD University of Maryland School of Medicine PFNCA 3/24/18

Faculty/Presenter Disclosure. Intracranial EEG Recording. Objectives. General Themes. Why invasive recordings? 6/27/2018

Responsive Neurostimulation for the Treatment of Refractory Partial Epilepsy. Summary

DEEP BRAIN AND CORTICAL STIMULATION

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

EVALUATION OF SURGERY FOR PARKINSON S DISEASE

Evaluation and Management of Parkinson s Disease in the Older Patient

Name of Policy: Deep Brain Stimulation

Subject: Magnetoencephalography/Magnetic Source Imaging

The Surgical Treatment of Epilepsy

Patient selection for surgery: Parkinson s disease

Traumatic Brain Injury:

Neuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.

Palladotomy and Pallidal Deep Brain Stimulation

Non-therapeutic and investigational uses of non-invasive brain stimulation

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association.

Understand the New 2019 Neurostimulator Analysis-Programming CPT Coding Structure and Associated Relative Value Units

Practice and Potential of Deep Brain Stimulation

DEEP BRAIN AND CORTICAL STIMULATION

EPILEPSY. New Ideas about an Old Disease. Gregory D. Cascino, MD

Indications. DBS for Tremor. What is the PSA? 6/08/2014. Tremor. 1. Tremor. 2. Gait freezing/postural instability. 3. Motor fluctuations

Epilepsy Surgery: Who should be considered? How will patients do? Bassel Abou-Khalil, M.D.

Clinical Policy Title: Deep brain stimulation

DEEP BRAIN AND CORTICAL STIMULATION

5/22/2009. Pediatric Neurosurgery Pediatric Neurology Neuroradiology Neurophysiology Neuropathology Neuropsychology

Medical Policy Deep Brain Stimulation. Description. Related Policies. Policy. Subsection. Effective Date February 27,

Case Report Subacute Subdural Hematoma in a Patient with Bilateral DBS Electrodes

Difficult-to-Localize Intractable Focal Epilepsy: An In-Depth Look

1/31/2009. Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function

The motor regulator. 1) Basal ganglia/nucleus

General remarks on Neurorejuvenation Spinal Cord Stimulation (SCS) Program Occipital Nerve Stimulation Gamma-knife for Trigeminal Neuralgia

Deep Brain Stimulation. Description

Accepted Manuscript. Editorial. Responsive neurostimulation for epilepsy: more than stimulation. Jayant N. Acharya

High-Field in vivo Visualization of the Human Globus Pallidus Using 7T MRI

Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA.

Transcription:

Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA. Shobana Rajan, M.D. Associate staff Anesthesiologist, Cleveland Clinic, Cleveland, Ohio This quiz is being published on behalf of the Education Committee of the SNACC..

The authors have no financial interests to declare in this presentation..

1. A 72-yr-old man with H/O Parkinson s disease ( PD) presents for deep brain stimulator ( DBS) placement. Contraindications for DBS include all of the following except, A. Coagulopathy B. Uncontrolled hypertension C. Permanent pacemaker D. Cognitive impairment Go to Q 2.

A. Coagulopathy Coagulopathy can be associated with an increased risk of intracranial hemorrhage. Hence coagulopathy is a contraindication for DBS placement

B. Uncontrolled hypertension Uncontrolled hypertsension is also associated with an increased risk of bleeding. Intracranial hematoma can be life threatening. Gorgulho et al. found that SBP <140 mmhg was associated with lower risk of intracerebral hemorrhage. Ref: Gorgulho A, De Salles AA, Frighetto L, et al. Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. J Neurosurg 2005;102:888 96.

Correct answer C. Permanent pacemaker A permanent pacemaker is not a contraindication for DBS placement., although precautions must be taken to limit possible DBS generator-ppm electrical interference Back to the Question Next Question

D. Cognitive impairment Cognitive impairment is the one of the most frequent causes of exclusion for DBS placement. Cognitive changes after STN- DBS can occur in patients without preoperative cognitive impairment and worsening of pre existing cognitive impairment after DBS. Ref: Krack P, Batir A, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson s disease. N Engl J Med 2003;349(20):1925 34.

2. Intraoperative seizures during awake craniotomy for resection of seizure foci can be aborted by the following measures EXCEPT A. Stop cortical mapping B. Ice cold saline applied directly to the cortical surface C. Propofol bolus D. Phenytoin bolus Go to Q 3.

A. Stop cortical mapping Most intra-operative seizures occur secondary to stimulation by cortical mapping. They are usually aborted by surgeon stopping the stimulus.

B. Ice cold saline applied directly to the cortical surface Most seizures that occur intraoperatively can be stopped by applying ice cold saline directly on the cortical surface. Ice cold saline reduces the seizure threshold and aborts the seizures.

C. Propofol bolus Seizures that do not stop by application of cold saline or stopping the stimulation will need to be treated with small doses of benzodiazepines, propofol bolus or barbiturates.

Correct answer D. Phentyoin bolus Risk factors for intraoperative seizures include surgical stimulation, hemorrhage, edema and ischemia. Phenytoin should be given as an infusion not as a bolus. Most patients present for resection of seizure foci because their seizures are not controlled by anti-epileptic medications. Additional phentyoin will not be useful, but may increase side effects. Back to the Question Next Question

3. Resection of seizure foci may involve measurement of the following except: A. EEG( electro-encephalography) B. ECoG ( electro-corticography) C MER( micro-electrode recording) D. MEP( motor evoked potentials) Go to Q 4.

A.EEG EEG is used commonly to diagnose seizures especially sub-clinical seizures.

B. ECoG ECoG is used intraoperatively to reproduce as a seizure aura. In some patients subdural grids are placed. Postoperatively, a period of ictal electrocorticographic recordings and cortical stimulation delineate the site of seizure onset and functional anatomy.

C. MER Correct answer Micro electrode recordings are used during placement of DBS. The MER demonstrate changes in spontaneous neuronal firing as the electrode enters the nuclear or thalamic brain tissue. The MER guide lead placement in DBS. Back to the Question Next Question

D. MEP Not used commonly. The seizure focus may lie in or near eloquent brain ( motor, sensory language, memory, vision). Mapping while the patient is awake is useful during surgical resection of intractable seizuer foci and minimize resection of eloquent areas of the brain. If the patient is not awake, MEP may be used in the rare situation.

4. Indications for DBS include all of the following EXCEPT A. Essential tremor B. Parkinson s disease C. Major depression D. Migraine headaches Go to Q 5.

A. Essential tremor Essential tremor may cause significant disability in otherwise healthy patients and significantly improves quality of life. DBS has been found to be very effective and received FDA approval in 1997. Ondo W, Jankovich J, Schwartz K, et al. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson disease tremor. Neurology 1998;51:1063 9.

B. Parkinson s disease Idiopathic Parkinson s disease associated with tremor at rest, rigidity, postural instability and bradykinesia. In patients suffering from drug induced complications or those refractory to medications, electrical stimulation of the deep brain structures ameliorates these symptoms. Kleiner-Fisman G, Fisman DN, Sime E et al. Long term follow-up of bilateral deep brain stimulation of the subthalamic nucleus stimulation in patients with advanced Parkinson s disease. J Neurosurg 2003; 99: 489-95

C. Major depression In studies done by Lozano et al, treatment resistant major despression responded favorably to subcallosal cingulate gyrus deep brain stimulation Lozano AM, Mayberg HS, Giacobbe P et al. Subcallosal stimulation for treatment-resistant depression. Biol Psychiatry 2008; 64(6):461-7

Correct answer D. Migraine headaches Current indications for DBS include essential tremor, idiopathic Parkinson s disease, dystonia. DBS is an emerging treatment in obsessive-compulsive disorder, refractory epilepsy, Tourette s syndrome, chronic pain, major depression and tremors( post stroke, post traumatic ) etc. Migraine headaches is not an indication for DBS placement. Back to the Question Next Question

5. A 72-yr-old man is undergoing DBS placement under MAC(monitored anesthesia care). Drugs to avoided include all EXCEPT A. Metoclopramide B. Meperidine C. Chlorpromazine D. Glycopyrrolate Back to Q 1.

A. Metoclopramide Metoclopramide blocks dopamine receptors, may cause drug induced Parkinson s disease and must be avoided in this patient. Ref: Ganzini L, Casey D, Hoffman W, McCali A. The prevalence of metoclopramide induced tardive dyskinesia and acute extrapyramidal movement disorders.arch Intern Med 1993; 153 (12) 1469-1475.

B. Meperidine Meperidine must be avoided in patients on MAOI inhibitors. Selegiline is used to treat Parkinson s disease is a MAOI-B type. Reports of agitation, muscle rigidity and hyperthermia have been described in patients on selegiline receiving meperidine.

C. Chlorpromazine Chlorpromazine may exacerbate PD symptoms. PD patients have dopamine deficiency and cholinergic excitation. Chlorpromazine promotes cholinergic activity and worsens PD symptoms.

Correct answer D Glycopyrrolate Glycopyrrolate is the preferred anticholinergic drug of choice since it does not cross the blood brain barrier. Hence does not exacerbate PD symtoms. End of set Back to the Question Back to Question 1